Download Gay And Bisexual African-American Men Have The Lowest Use Of

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Public health genomics wikipedia , lookup

Health equity wikipedia , lookup

Race and health wikipedia , lookup

Reproductive health wikipedia , lookup

Rhetoric of health and medicine wikipedia , lookup

Preventive healthcare wikipedia , lookup

Race and health in the United States wikipedia , lookup

Transcript
Gay And Bisexual African-American Men Have The Lowest Use Of Prostate Testing
31 Dec 2008
Gay and bisexual black men are less likely to be tested for prostate cancer than men of any
racial and ethnic backgrounds regardless of their sexual orientation, according to a recent st
researcher at Charles Drew University of Medicine and Science.
In his study, published in the December issue of Medical Care, Kevin C. Heslin, an assistant
at Charles Drew University, examined prostate and colorectal testing rates based on sexual
orientation, race and ethnicity.
Using data from telephone interviews with 19,410 men who participated in the California Hea
Interview Survey, the research found no overall difference in the use of the prostate-specific
(or PSA) test among gay, bisexual and heterosexual men.
But the percentage of gay and bisexual black men who received the PSA test was 12% to 14
than heterosexual blacks and 15% to 28% lower than gay and bisexual whites.
"Gay and bisexual black men had the lowest use of the PSA test, compared with every other
men in the study," Heslin said. "For blacks, being a member of both racial and sexual minori
represents a kind of double jeopardy when it comes to getting PSA testing."
The findings are significant because black men are more likely to be diagnosed late with pro
cancer and, as a result, are more likely to die from the disease than any other racial or ethnic
Prostate and colorectal cancers are the second and third most common causes of cancer de
among men in the United States, exceeded only by lung cancer.
Overall, the study found that a greater percentage of gay and bisexual men received colorec
tests compared with heterosexual men, which suggests that gay and bisexual men may have
access to preventive screening than heterosexuals. But the researchers point out that the dif
may be partly due to the fact that colorectal cancer tests - such as colonoscopy, sigmoidosco
proctoscopy - are also used to diagnose sexual health problems among gay men.
All the men in the study were age 50 and over, which is the age at which screening for prost
colorectal cancer is recommended by many professional organizations. The American Canc
guidelines recommend that African American males begin receiving the PSA screening test
Funded by the National Institutes of Health (NIH), the study, "Sexual Orientation and Testing
Prostate and Colorectal Cancers among Men in California," suggests that health services pla
seeking to address racial and ethnic disparities in prostate cancer may need to consider sex
orientation when developing culturally specific screening programs for high-risk subgroups o
such as African Americans.
Kevin C. Heslin received his Ph.D. in Health Services Research from the University of Califo
Angeles (UCLA). He was a pre-doctoral fellow in the National Institute of Mental Health/UCL
Research Training Program. He is currently an assistant professor at Charles Drew Universi
Medicine and Science. His research focuses on access to health services and health outcom
underserved populations, particularly persons with HIV/AIDS and homeless persons.
ABOUT CHARLES DREW UNIVERSITY OF MEDICINE AND SCIENCE (CDU)
CDU is a private nonprofit, nonsectarian, minority-serving medical and health sciences institu
Located in the Watts-Willowbrook area of South Los Angeles, CDU has graduated over 550
doctors, 2,500 post-graduate physicians, more than 2,000 physician assistants and hundred
health professionals. The only dually designated Historically Black Graduate Institution and H
Serving Health Professions School in the U.S. CDU is recognized as a leader in health inequ
translational research, specifically with respect to heart disease, diabetes, cancer, mental he
HIV/AIDS. The University is among the top 7% of National Institutes of Health (NIH)-funded
and rated one of the top 50 private universities in research in the U.S. Recently, the CDU/UC
medical program was named the "best performer" in the University of California System with
producing outstanding underrepresented minority physicians. For more information, visit
www.cdrewu.edu.
Article URL: http://www.medicalnewstoday.com/articles/134146.php
Main News Category: Prostate / Prostate Cancer
Also Appears In: Urology / Nephrology,
Any medical information published on this website is not intended as a
substitute for informed medical advice and you should not take any action
before consulting with a health care professional. For more information,
please read our terms and conditions.
Save time! Get the latest medical news headlines for your specialist area, in
a weekly newsletter e-mail. See
http://www.medicalnewstoday.com/newsletters.php for details.
Send your press releases to [email protected]